Apyx Medical Corp
(APYX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,176 | -7,590 | -18,850 | -9,226 | -4,551 |
| Depreciation Amortization | 313 | 157 | 692 | 540 | 354 |
| Accounts receivable | 1,187 | 1,478 | -3,574 | -2,192 | -1,441 |
| Accounts payable and accrued liabilities | -345 | -599 | 25 | -613 | -26 |
| Other Working Capital | 385 | -315 | 5,543 | 3,290 | -3,157 |
| Other Operating Activity | 1,966 | 528 | 10,915 | 5,164 | 2,088 |
| Operating Cash Flow | $-10,670 | $-6,341 | $-5,249 | $-3,037 | $-6,733 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -324 | -35 | 6,734 | 6,827 | 7,001 |
| Investing Cash Flow | $-324 | $-35 | $6,734 | $6,827 | $7,001 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 2,632 | N/A | 586 |
| Debt Issued | N/A | N/A | 43,474 | 9,289 | 9,289 |
| Debt Repayment | -10 | -5 | -37 | -32 | -19 |
| Common Stock Issued | N/A | N/A | 86 | 672 | 56 |
| Other Financing Activity | 0 | 0 | -13,989 | -1,607 | -1,754 |
| Financing Cash Flow | $-10 | $-5 | $32,166 | $8,322 | $8,158 |
| Exchange Rate Effect | 30 | 11 | -191 | -170 | -139 |
| Beginning Cash Position | 43,652 | 43,652 | 10,192 | 10,192 | 10,192 |
| End Cash Position | 32,678 | 37,282 | 43,652 | 22,134 | 18,479 |
| Net Cash Flow | $-10,974 | $-6,370 | $33,460 | $11,942 | $8,287 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,670 | -6,341 | -5,249 | -3,037 | -6,733 |
| Capital Expenditure | -324 | -35 | -533 | -440 | -266 |
| Free Cash Flow | -10,994 | -6,376 | -5,782 | -3,477 | -6,999 |